Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
FRANCE – Sanofi has collaborated with the Californian biotechnology company Scribe Therapeutics to develop new cancer cell therapies. Under the terms of the deal, Sanofi picks up non-exclusive rights to…
Read More
INDIA – Pharma majors GSK and Sanofi may have a negative impact on their revenues after the central government has included drugs manufactured by these companies into the updated national…
Read More
FRANCE- Sanofi has decided to stop developing amcenestrant, a once-promising breast cancer medication, after a second unsuccessful clinical trial, striking a setback to its pipeline of potential new medicines. The…
Read More
FRANCE – French Pharma giant Sanofi has halted development of lademirsen, discovered by Regulus Therapeutics, after the program failed a Phase II interim analysis. Sanofi added that the move was…
Read More
FRANCE – Sanofi Global Health has launched a new brand of standard of care medicines produced by Sanofi dedicated for nonprofit distribution to at-risk populations in the low-income countries. Sanofi…
Read More
UAE – The Abu Dhabi Department of Health (DoH) and France’s Sanofi, a global healthcare leader, have signed a Declaration of Collaboration to join forces in four strategic healthcare areas.…
Read More
INDIA – Pharma major Sanofi India has announced the appointment of Preeti Futnani as the company’s General Manager – Vaccines. Futnani was the franchise head for Dupixent Dermatology at Sanofi’s…
Read More
USA – Sanofi and Regeneron have added another string to the bow of their immunology blockbuster Dupixent with an FDA approval for treatment of oesophagitis (EoE), which could help the…
Read More
SINGAPORE – French pharmaceutical company, Sanofi has begun construction on the first of two so-called Evolutive Vaccine Facilities (EVFs) it is constructing with a total investment of 900 million euros…
Read More
INDIA –Sanofi India (SIL) announced that Rodolfo Hrosz has been appointed as the Company’s new Managing Director, effective June 1, 2022, subject to regulatory approvals. He will move from his…
Read More